Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

DOC2B Polyclonal antibody

DOC2B Polyclonal Antibody for WB, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IF/ICC, CoIP, ELISA

Doc2 beta, DOC2B, DOC2BL, double C2 like domains, beta

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for DOC2B in ?

Tested Applications

Positive WB detected inHEK-293 cells, mouse brain tissue, mouse kidney tissue
Positive IF/ICC detected inHepG2 cells, Hela cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:4000
Immunofluorescence (IF)/ICCIF/ICC : 1:10-1:100
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

20574-1-AP targets DOC2B in WB, IF/ICC, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

Peptide

Predict reactive species
Full Name double C2-like domains, beta
Calculated Molecular Weight 46 kDa
Observed Molecular Weight 46 kDa
GenBank Accession NumberNM_003585
Gene Symbol DOC2B
Gene ID (NCBI) 8447
RRIDAB_10696316
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ14184
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

DOC2B may be involved in constitutive membrane trafficking including dynein-dependent intracellular vesicle transport. In vitro, binds calcium and phospholipids. The antibody is specific to DOC2B.

Protocols

Product Specific Protocols
IF protocol for DOC2B antibody 20574-1-APDownload protocol
WB protocol for DOC2B antibody 20574-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The anti-DOC2B antibody (Cat# 20574-1-AP) has 9 citations published in journals including Science Advances, Pharmacological Research, Cell Communication and Signaling, Diabetes, Free Radical Biology and Medicine, Journal of Biological Chemistry, Scientific Reports, International Journal of Molecular Sciences, and Cell Biology and Toxicology. Research fields span cervical cancer biology, Wnt/β-catenin signaling, mitochondrial dysfunction, lipotoxicity, β-cell protection, epithelial-mesenchymal transition, glucose uptake regulation, and neurotransmitter release.

SpeciesApplicationTitle
human,mouseWB,IF

Sci Adv

Phosphorylation of Doc2 by EphB2 modulates Munc13-mediated SNARE complex assembly and neurotransmitter release

Authors - Hong Zhang
humanWB,CoIP

Pharmacol Res

DOC2B is a negative regulator of Wnt/β-catenin signaling pathway in cervical cancer.

Authors - Divya Adiga
  • KD Validated
humanWB

Cell Commun Signal

The ester derivative Palmitoylcarnitine abrogates cervical cancer cell survival by enhancing lipotoxicity and mitochondrial dysfunction

Authors - Sangavi Eswaran
mouseWB,IF

Diabetes

Doc2b Protects β-Cells Against Inflammatory Damage and Enhances Function.

Authors - Arianne Aslamy
  • KO Validated
humanWB,IF

Free Radic Biol Med

Double C-2 like domain beta (DOC2B) induces calcium dependent oxidative stress to promote lipotoxicity and mitochondrial dysfunction for its tumor suppressive function

Authors - Divya Adiga
humanWB

Cell Biol Toxicol

Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence.

Authors - Samatha Bhat
  • KD Validated
Loading...
||
New chat

Able™

正在加载,请稍候...